The crude mortality rates were 11.9 per 1000 person- years for simvastatin, 12.2 for cerivastatin, 11.0 for atorvastatin, 10.8 for pravastatin, and 12.1 for fluvastatin, as compared with 7.9 for fibrates, 5.5 in the untreated group and 17.5 during the non- compliance period of patients treaded with hypolipidaemic agents at some point.